Insider filing · RCUS
Terry J Rosen
Chief Executive Officer
profile →
Arcus Biosciences, Inc.
RCUS · Healthcare · 21 filings in 24 months
ticker →
Terry J Rosen sold $1.2M of Arcus Biosciences (RCUS)
Executed Dec 16 2025, disclosed Dec 18 2025, 2 days later.
Value, as filed
$1.2M
54,691 sh across 2 lots
Executed
Dec 16 2025
the trade date, as filed
Disclosed
Dec 18 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TRTerry J Rosen (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arcus Biosciences, Inc. (RCUS). The largest single filing was $1.2M of RCUS (54,691 sh across 2 lots, as filed), executed Dec 16 2025.
The name
RCUSHealthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Terry J Rosen in RCUS
RCUSPURCHASE
Arcus Biosciences, Inc.
$202K19,800 sh × $10.18
Exec Feb 27 2025
Filed Feb 27 2025 · 5:30 PM ET